412 related articles for article (PubMed ID: 30411685)
1. Role of HIF-1 in Cancer Progression: Novel Insights. A Review.
Pezzuto A; Carico E
Curr Mol Med; 2018; 18(6):343-351. PubMed ID: 30411685
[TBL] [Abstract][Full Text] [Related]
2. Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein.
Song X; Yao J; Wang F; Zhou M; Zhou Y; Wang H; Wei L; Zhao L; Li Z; Lu N; Guo Q
Toxicol Appl Pharmacol; 2013 Sep; 271(2):144-55. PubMed ID: 23707765
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?
Huang Y; Lin D; Taniguchi CM
Sci China Life Sci; 2017 Oct; 60(10):1114-1124. PubMed ID: 29039125
[TBL] [Abstract][Full Text] [Related]
5. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
7. Transgenic models to understand hypoxia-inducible factor function.
Doedens A; Johnson RS
Methods Enzymol; 2007; 435():87-105. PubMed ID: 17998050
[TBL] [Abstract][Full Text] [Related]
8. TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development.
Yang MH; Wu KJ
Cell Cycle; 2008 Jul; 7(14):2090-6. PubMed ID: 18635960
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of HIF-1A and its implication in the hypoxia pathway in primary advanced uterine cervical carcinoma.
Łuczak MW; Roszak A; Pawlik P; Kędzia H; Lianeri M; Jagodziński PP
Oncol Rep; 2011 Nov; 26(5):1259-64. PubMed ID: 21887475
[TBL] [Abstract][Full Text] [Related]
10. The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease.
Haase VH
Kidney Int; 2006 Apr; 69(8):1302-7. PubMed ID: 16531988
[TBL] [Abstract][Full Text] [Related]
11. Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel-Lindau-dependent pathway.
Li CH; Liao PL; Yang YT; Huang SH; Lin CH; Cheng YW; Kang JJ
Arch Toxicol; 2014 Mar; 88(3):659-71. PubMed ID: 24292262
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
[TBL] [Abstract][Full Text] [Related]
13. Involvement of hypoxia-inducible factor 1 in human cancer.
Semenza GL
Intern Med; 2002 Feb; 41(2):79-83. PubMed ID: 11868612
[TBL] [Abstract][Full Text] [Related]
14. Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.
Maynard MA; Ohh M
Am J Nephrol; 2004; 24(1):1-13. PubMed ID: 14654728
[TBL] [Abstract][Full Text] [Related]
15. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
[TBL] [Abstract][Full Text] [Related]
16. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
Tanimoto K; Makino Y; Pereira T; Poellinger L
EMBO J; 2000 Aug; 19(16):4298-309. PubMed ID: 10944113
[TBL] [Abstract][Full Text] [Related]
18. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
Carroll VA; Ashcroft M
Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hypoxia inducible factor-1α downregulates the expression of epithelial to mesenchymal transition early marker proteins without undermining cell survival in hypoxic lens epithelial cells.
Cammarata PR; Neelam S; Brooks MM
Mol Vis; 2015; 21():1024-35. PubMed ID: 26392741
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression.
Yang G; Shi R; Zhang Q
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]